Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study have?
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study has 719 citations in the OpenAlex counts ScholarIQ stores.
When was Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study published?
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study has 2001 year in the ScholarIQ index.
What is the open-access status of Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study?
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study has closed oa status in the ScholarIQ index.
What is the DOI of Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study?
The DOI for Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study is on the source record.
What is the PMID of Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study?
The PMID for Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study is on the source record.
What is the OpenAlex record for Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study?
The OpenAlex for Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study is on the source record.